Systems and methods for identifying protein stabilizers
Abstract
A device for studying protein conformation transformation can include a macroscopic substrate, and chaperonin proteins bound to the substrate, each chaperonin protein being capable of binding to a protein of interest during or after undergoing protein conformation transformation. The device may also include the proteins of interest bound to the substrate, where the substrate is included in a label-free assay system. A method of studying protein conformation transformation can include: providing a macroscopic substrate bound with the chaperonin protein and immersing the chaperonin protein in a study composition having the protein of interest, or include providing a macroscopic substrate bound with the protein of interest; and immersing the protein in a study composition having the chaperonin. Such a method can be done with and without a potential stabilizer in order to determine whether the potential stabilizer stabilizes the protein of interest.
Claims
exact text as granted — not AI-modified1 . A device for studying protein conformation transformation, the device comprising:
a macroscopic substrate; and one or more chaperonin proteins or functional portion thereof bound to the substrate, each chaperonin protein being capable of binding to a protein of interest during or after undergoing protein conformation transformation, the protein of interest being capable of undergoing protein conformation transformation at physiological conditions.
2 . The device of claim 1 , comprising the macroscopic substrate being immersed in a composition having a protein susceptible of undergoing protein conformation transformation.
3 . The device of claim 1 , wherein the device is configured for:
biolayer interferometry (BLI); or surface plasmon resonance (SPR); or any label-free system device.
4 . (canceled)
5 . (canceled)
6 . The device of claim 1 , wherein a nonfunctional portion of the chaperonin protein is bound to the substrate, wherein
optionally the chaperonin protein is bound to the substrate through direct amine coupling, antibody capture, or biotin/streptavidin affinity.
7 . (canceled)
8 . The device of claim 1 , wherein the substrate is:
a probe; or biolayer interferometry (BLI) probe; or a biochemical chip; or an assay surface of an assay surface array plate; or a well surface of a plate; or an assay surface array plate.
9 . (canceled)
10 . (canceled)
11 . (canceled)
12 . (canceled)
13 . A device for studying protein conformation transformation, the device comprising:
a macroscopic substrate; one or more proteins of interest or functional portion thereof bound to the substrate, the protein being susceptible of undergoing protein conformation transformation at physiological conditions; and a label-free assay system having the one or more proteins of interest bound to the macroscopic substrate.
14 . The device of claim 13 , comprising the macroscopic substrate being immersed in a composition having one or more chaperonin proteins each capable of binding to the protein of interest during or after undergoing protein conformation transformation.
15 . (canceled)
16 . The device of claim 13 , wherein the protein of interest is bound to the macroscopic substrate through a linker, the linker optionally selected from the group consisting of a polymer, hydrocarbon, antibody, chimeric construct, GST domain, histidine tag, SUMO tag, or combination thereof.
17 . (canceled)
18 . The device of claim 13 , wherein:
a nonfunctional portion of the protein of interest is bound to the substrate; or the protein of interest is bound to the substrate through direct amine coupling, antibody capture, or biotin/streptavidin affinity.
19 . (canceled)
20 . The device of claim 13 , wherein the substrate is:
a probe; or biolayer interferometry (BLI) probe; or a biochemical chip; or an assay surface of an assay surface array plate; or a well surface of a plate; or an assay surface array plate.
21 . (canceled)
22 . (canceled)
23 . (canceled)
24 . (canceled)
25 . (canceled)
26 . (canceled)
27 . (canceled)
28 . (canceled)
29 . (canceled)
30 . (canceled)
31 . A system for studying protein conformation transformation, the system comprising:
the device of claim 1 ; and a liquid composition having the protein of interest soluble in the liquid.
32 . A system for studying protein conformation transformation, the system comprising:
the device of claim 13 ; and a liquid composition having the chaperonin soluble in the liquid.
33 . The system of claim 31 , comprising one or more of:
one or more potential protein stabilizers; a control composition having dihydrofolate reductase (DHFR) as a control; one or more potential protein destabilizers; a positive control protein stabilizer; a composition including an osmolyte; or a composition including a denaturant.
34 . The system of claim 32 , comprising one or more of:
one or more potential protein destabilizers; a control composition having dihydrofolate reductase (DHFR) as a control; one or more potential protein stabilizers; a positive control protein stabilizer; a composition including an osmolyte; or a composition including a denaturant.
35 . (canceled)
36 . (canceled)
37 . (canceled)
38 . (canceled)
39 . (canceled)
40 . (canceled)
41 . (canceled)
42 . (canceled)
43 . (canceled)
44 . (canceled)
45 . A method of studying protein conformation transformation, the method comprising:
providing the device of claim 1 having the macroscopic substrate bound with the chaperonin protein; and immersing the chaperonin protein in a study composition having the protein of interest.
46 . The method of studying protein conformation transformation, the method comprising:
providing the device of claim 13 having the macroscopic substrate bound with the protein of interest; and immersing the protein in a study composition having the chaperonin.
47 . The method of claim 45 , comprising:
introducing a potential protein stabilizer into the study composition; and determining whether the potential protein stabilizer is a protein stabilizer for the protein of interest.
48 . The method of claim 45 , comprising:
monitoring kinetics of interaction between the chaperonin and the protein of interest with or without presence of potential protein stabilizer.
49 . The method of claim 45 , comprising:
determining a potential protein stabilizer to be a protein stabilizer for the protein of interest at a desired pH value or range.
50 . (canceled)
51 . (canceled)
52 . The method of claim 45 , comprising:
monitoring dynamic folding and/or unfolding of the protein of interest with or without the potential protein stabilizer.
53 . (canceled)
54 . (canceled)
55 . (canceled)
56 . The method of claim 45 , comprising:
introducing a potential protein destabilizer into the study composition; and determining whether the potential protein destabilizer is a protein destabilizer for the protein of interest.
57 . (canceled)
58 . (canceled)
59 . (canceled)
60 . (canceled)
61 . (canceled)
62 . (canceled)
63 . (canceled)
64 . (canceled)
65 . (canceled)
66 . The method of claim 45 , comprising:
determining whether or not a potential protein stabilizer inhibits aggregation of the protein of interest.
67 . (canceled)
68 . (canceled)
69 . (canceled)
70 . A method of studying protein aggregation, the method comprising:
providing the device of claim 1 having the macroscopic substrate bound with the chaperonin protein; immersing the chaperonin protein in a study composition having the protein of interest and a potential protein stabilizer; and determining whether or not the potential protein stabilizer inhibits aggregation of the protein of interest.
71 . A method of studying protein aggregation, the method comprising:
providing the device of claim 13 having the macroscopic substrate bound with the protein of interest; and immersing the protein of interest in an study composition having the chaperonin and a potential protein stabilizer; and determining whether or not the potential protein stabilizer inhibit aggregation of the protein of interest.
72 . (canceled)
73 . The method of claim 46 , comprising:
introducing a potential protein stabilizer into the study composition; and determining whether the potential protein stabilizer is a protein stabilizer for the protein of interest.
74 . The method of claim 46 , comprising:
monitoring kinetics of interaction between the chaperonin and the protein of interest with or without presence of potential protein stabilizer.
75 . The method of claim 46 , comprising:
determining a potential protein stabilizer to be a protein stabilizer for the protein of interest at a desired pH value or range.
76 . The method of claim 46 , comprising:
monitoring dynamic folding and/or unfolding of the protein of interest with or without the potential protein stabilizer.
77 . The method of claim 46 , comprising:
introducing a potential protein destabilizer into the study composition; and determining whether the potential protein destabilizer is a protein destabilizer for the protein of interest.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.